Diabetes-related mortality in adults with cystic fibrosis: Role of genotype and sex

American Journal of Respiratory and Critical Care Medicine

Volumn 191, Issue 2, 2015, Pages 194-200

  Lewis, Connor ^a   Blackman, Scott M ^b   Nelson, Amanda ^c   Oberdorfer, Ewa ^d   Wells, Daniel ^d   Dunitz, Jordan ^d   Thomas, William ^e   Moran, Antoinette ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEHARRY MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cystic fibrosis related diabetes; Prognosis; Sex differences; Survival

Indexed keywords

ADULT; ARTICLE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE; DIABETES MELLITUS; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MORTALITY; PANCREAS INSUFFICIENCY; POPULATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SURVIVAL; AGE DISTRIBUTION; COMPLICATION; DISEASE COURSE; GENETICS; SEX RATIO; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84921327918     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201403-0576OC     Document Type: Article

References (26)

1. Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu SC, Klein DJ. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988;112:373-377.
2. Rosenecker J, Höfler R, Steinkamp G, Eichler I, Smaczny C, Ballmann M, Posselt H-G, Bargon J, von der Hardt H. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res 2001;6:345-350.
3. Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005;28:2141-2144.
4. Sims EJ, Green MW, Mehta A. Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes. Diabetes Care 2005;28:1581-1587.
5. Chamnan P, Shine BSF, Haworth CS, Bilton D, Adler AI. Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care 2010;33:311-316.
6. Kien CL, Zipf WB, Horswill CA, Denne SC, McCoy KS, O'Dorisio TM. Effects of feeding on protein turnover in healthy children and in children with cystic fibrosis. Am J Clin Nutr 1996;64:608-614.
7. Hardin DS, LeBlanc A, Lukenbaugh S, Para L, Seilheimer DK. Proteolysis associated with insulin resistance in cystic fibrosis. Pediatrics 1998; 101:433-437.
8. Moran A, Milla C, Ducret R, Nair KS. Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance. Diabetes 2001;50:1336-1343.
9. Moran A, Basu R, Milla C, Jensen MD. Insulin regulation of free fatty acid kinetics in adult cystic fibrosis patients with impaired glucose tolerance. Metabolism 2004;53:1467-1472.
10. Rafii M, Chapman K, Stewart C, Kelly E, Hanna A, Wilson DC, Tullis E, Pencharz PB. Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis. Am J Clin Nutr 2005;81:421-426.
11. Brennan AL, Gyi KM, Wood DM, Johnson J, Holliman R, Baines DL, Philips BJ, Geddes DM, Hodson ME, Baker EH. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros 2007;6:101-109.
12. Ntimbane T, Krishnamoorthy P, Huot C, Legault L, Jacob SV, Brunet S, Levy E, Guéraud F, Lands LC, Comte B. Oxidative stress and cystic fibrosis-related diabetes: a pilot study in children. J Cyst Fibros 2008; 7:373-384.
13. Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009;32:1626-1631.
14. Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, Robinson KA, Sabadosa KA, Stecenko A, Slovis B; CFRD Guidelines Committee. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010;33:2697-2708.
15. Sosnay PR, Siklosi KR, Van Goor F, Kaniecki K, Yu H, Sharma N, Ramalho AS, Amaral MD, Dorfman R, Zielenski J, et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet 2013;45:1160-1167.
16. Blackman SM, Commander CW, Watson C, Arcara KM, Strug LJ, Stonebraker JR, Wright FA, Rommens JM, Sun L, Pace RG, et al. Genetic modifiers of cystic fibrosis-related diabetes. Diabetes 2013; 62:3627-3635.
17. Bradley GM, Blackman SM, Watson CP, Doshi VK, Cutting GR. Genetic modi fiers of nutritional status in cystic fibrosis. Am J Clin Nutr 2012; 96:1299-1308.
18. Moran A, Pekow P, Grover P, Zorn M, Slovis B, Pilewski J, Tullis E, Liou TG, Allen H; Cystic Fibrosis Related Diabetes Therapy Study Group. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial. Diabetes Care 2009;32:1783-1788.
19. Moran A, Becker D, Casella SJ, Gottlieb PA, Kirkman MS, Marshall BC, Slovis B. Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review. Diabetes Care 2010;33:2677-2683.
20. Kerem E, Kerem B. The relationship between genotype and phenotype in cystic fibrosis. Curr Opin Pulm Med 1995;1:450-456.
21. Ahmed N, Corey M, Forstner G, Zielenski J, Tsui L-C, Ellis L, Tullis E, Durie P. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 2003; 52:1159-1164.
22. Blackman SM, Hsu S, Vanscoy LL, Collaco JM, Ritter SE, Naughton K, Cutting GR. Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis. J Clin Endocrinol Metab 2009;94: 1302-1309.
23. Lai HJ, Cheng Y, Cho H, Kosorok MR, Farrell PM. Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis. Am J Epidemiol 2004;159:537-546.
24. Boom A, Lybaert P, Pollet JF, Jacobs P, Jkijaki H, Golstein PE, Sener A, Malaisse WJ, Beauwens R. Expression and localization of CFTR in the rat endocrine pancreas. Endocr Pract 2008;32:197-205.
25. Edlund A, Huhn M, Flodstrom-Tullberg M, Eliasson L. 2010. Active CFTR channels are important for insulin and glucagon secretion. Acta Physiol 198;(Suppl. 677):P-MON-66
26. Bellin MD, Laguna T, Leschyshyn J, Regelmann W, Dunitz J, Billings J, Moran A. Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study. Pediatr Diabetes 2013;14:417-421.